Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar

NCT00895674 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00895674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00895674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
July 31, 2006
Completion date
August 31, 2010
Enrollment
2,840 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, renal cell, carcinoma, renal cell (advanced)